Real-world adverse events with niraparib 200 mg/day maintenance therapy in ovarian cancer: a retrospective study

Future Oncology, Ahead of Print.

Source: Future Oncology - November 10, 2019 Category: Cancer & Oncology Authors: Jack R Gallagher Kylee Jean Heap Susan Carroll Karin Travers Brooke Harrow Shannon N Westin Source Type: research